Proposed Data Collection Submitted for Public Comment and Recommendations, 3548-3549 [2022-01262]
Download as PDF
<![CDATA[
3548
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-22–1308; Docket No. CDC–2022–
0007]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Validated Follow-up Interview of
Clinicians on Outpatient Antibiotic
Stewardship Interventions. This
collection aims to perform an interview
of outpatient clinicians regarding the
acceptability and perceived clinician
level barriers associated with our yearlong implementation of interventions
designed around the Core Elements of
Outpatient Antibiotic Stewardship.
DATES: CDC must receive written
comments on or before March 25, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0007 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
SUMMARY:
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
Proposed Project
Validated Interview and Survey of
Outpatient Providers on Antibiotic
Stewardship Interventions (OMB
Control No. 0920–1308)—
Reinstatement—Division of Healthcare
Quality Promotion (DHQP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Inappropriate antibiotic prescribing is
a major driver of antibiotic resistance
which is an urgent national and global
health threat. Additionally,
inappropriate antibiotic prescribing
contributes to avoidable adverse drug
events that cause substantial harm to
patients. Most antibiotic prescribing
originates in traditional outpatient
settings such as physician offices and
emergency departments and at least
30% of these prescriptions are
completely unnecessary. Over the past
decade there has been rapid growth in
non-traditional outpatient settings
including Urgent Care clinics. Recent
evidence shows that when compared to
traditional office settings, inappropriate
antibiotic prescribing is substantially
higher in Urgent Care clinics making
this an important priority for antibiotic
stewardship. The design, development,
and evaluation of durable stewardship
interventions addressing the unique
setting of Urgent Care clinics is an
important area of unmet need. This data
will assess knowledge, attitudes, and
practices related to antibiotic
prescribing among clinicians after
implementation of a year-long Urgent
Care stewardship initiative.
CDC requests approval for an
estimated 62 annual burden hours.
There is no cost to respondents other
than their time.
jspears on DSK121TN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
Urgent Care Clinician ........................................
Urgent Care Clinician ........................................
Interview Guide .................................................
Survey ...............................................................
20
125
1
1
1
20/60
20
42
Total ............................................................
...........................................................................
........................
........................
........................
62
VerDate Sep<11>2014
18:11 Jan 21, 2022
Jkt 256001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\24JAN1.SGM
24JAN1
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–01262 Filed 1–21–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), ICD–10 Coordination and
Maintenance (C&M) Committee
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of virtual meeting.
The CDC, National Center for
Health Statistics (NCHS), Classifications
and Public Health Data Standards Staff,
announces the following meeting of the
ICD–10 Coordination and Maintenance
(C&M) Committee meeting. This
meeting is open to the public, limited
only by audio lines available. Online
Registration is not required.
SUMMARY:
The meeting will be held on
March 8, 2022, from 9:00 a.m. to 5:00
p.m., EST, and March 9, 2022, from 9:00
a.m. to 5:00 p.m., EST.
DATES:
This is a virtual meeting.
Information will be provided on each of
our respective web pages when it
becomes available. For CDC/NCHS
https://www.cdc.gov/nchs/icd/icd10cm_
maintenance.htm. For CMS https://
www.cms.gov/Medicare/Coding/
ICD9ProviderDiagnosticCodes/meetings.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Traci Ramirez, Medical Systems
Specialist, CDC, 3311 Toledo Road,
Hyattsville, Maryland 20782,
Telephone: (301) 458–4454; Email:
TRamirez@cdc.gov.
jspears on DSK121TN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
Matters To Be Considered: The
tentative agenda will include
discussions on ICD–10–CM and ICD–
10–PCS topics listed below. Agenda
items are subject to change as priorities
dictate. Please refer to the posted agenda
for updates one month prior to the
meeting.
VerDate Sep<11>2014
18:11 Jan 21, 2022
Jkt 256001
ICD–10–PCS Topics
1. Administration of Spesolimab *
2. Administration of daratumumab and
hyaluronidase-fihj *
3. Administration of Defencath *
4. Administration of Maribavir *
5. Administration of Teclistamab *
6. Administration of Mosunetuzumab *
7. Administration of afamitresgene
autoleucel **
8. Administration of tabelecleucel **
9. Administration of Treosulfan *
10. Administration of inebilizumab-cdon *
11. Administration of Xenon-129 *
12. Administration of betibeglogene
autotemcel **
13. Administration of Omidubicel **
14. Implantation of Sphenopalatine Ganglion
Stimulator for Ischemic Stroke *
15. Gene Expression Assay **
16. Vertebral Body Tethering *
17. Percutaneous Femoral-Popliteal Artery
Bypass *
18. Computer-Assisted Transcranial Magnetic
Stimulation *
19. Computer-Aided Analysis for the
Detection and Classification of Epileptic
Events *
20. Facet Replacement Spinal Stabilization
Device *
21. Insertion of Sacropelvic Fixation
System *
22. Insertion of an Implantable Vagus Nerve
Stimulation System *
23. Insertion of a Paired Vagus Nerve
Stimulation System *
24. Percutaneous Venous Thrombectomy for
Postthrombotic Syndrome *
25. Quantitative Flow Ratio for Non-invasive
Intraprocedural Analysis of Cardiac
Angiography
26. Application of Allogeneic Thymus
Derived Tissue
27. Supersaturated Oxygen Therapy
28. Assistance with Precision Stimulation
Software *
29. Section X Updates
30. Addenda and Key Updates
* Requestor has submitted a New
Technology Add-on Payment (NTAP)
application for FY 2023.
** Requestor intends to submit an
NTAP application for FY 2024
consideration.
Presentations for procedure code
requests are conducted by both the
requestor and CMS during the
Coordination & Maintenance Committee
meeting. Discussion from the requestor
generally focuses on the clinical issues
for the procedure or technology,
followed by the proposed coding
options from a CMS analyst. Topics
presented may also include requests for
new procedure codes that relate to a
new technology add-on payment
(NTAP) policy request.
CMS is continuing to modify the
approach for presenting the new
technology add-on payment (NTAP)
related ICD–10–PCS procedure code
requests that involve the administration
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
3549
of a therapeutic agent for the March 8–
9, 2022 ICD–10 Coordination and
Maintenance Committee meeting.
Consistent with the requirements of
section 1886(d)(5)(K)(iii) of the Social
Security Act, applicants submitted
requests to create a unique procedure
code to describe the administration of a
therapeutic agent, such as the option to
create a new code in Section X within
the ICD–10–PCS procedure code
classification. CMS will initially only
display those meeting materials
associated with the NTAP related ICD–
10–PCS procedure code requests that
involve the administration of a
therapeutic agent on the CMS website in
early February 2022 at: https://
www.cms.gov/Medicare/Coding/ICD10/
C-and-M-Meeting-Materials.
The 13 NTAP related ICD–10–PCS
procedure code requests that involve the
administration of a therapeutic agent
are:
1. Administration of Spesolimab *
2. Administration of daratumumab and
hyaluronidase-fihj *
3. Administration of Defencath *
4. Administration of Maribavir *
5. Administration of Teclistamab *
6. Administration of Mosunetuzumab *
7. Administration of afamitresgene
autoleucel **
8. Administration of tabelecleucel **
9. Administration of Treosulfan *
10. Administration of inebilizumab-cdon *
11. Administration of Xenon-129 *
12. Administration of betibeglogene
autotemcel **
13. Administration of Omidubicel **
These topics will not be presented
during the March 8–9, 2022 meeting.
CMS will solicit public comments
regarding any clinical questions or
coding options included for these 13
procedure code topics in advance of the
meeting continuing through the end of
the public comment period, April 8,
2022. Members of the public should
send any questions or comments to the
CMS mailbox at: ICDProcedure
CodeRequest@cms.hhs.gov by the April
8, 2022 deadline.
CMS intends to post a question and
answer document in advance of the
meeting to address any clinical or
coding questions that members of the
public may have submitted. Following
the conclusion of the meeting, CMS will
post an updated question and answer
document to address any additional
clinical or coding questions that
members of the public may have
submitted during the meeting that CMS
was not able to address or that were
submitted after the meeting.
The NTAP related ICD–10–PCS
procedure code requests that do not
involve the administration of a
E:\FR\FM\24JAN1.SGM
24JAN1
]]>Agencies
[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Pages 3548-3549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01262]
[[Page 3548]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1308; Docket No. CDC-2022-0007]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Validated Follow-up Interview of
Clinicians on Outpatient Antibiotic Stewardship Interventions. This
collection aims to perform an interview of outpatient clinicians
regarding the acceptability and perceived clinician level barriers
associated with our year-long implementation of interventions designed
around the Core Elements of Outpatient Antibiotic Stewardship.
DATES: CDC must receive written comments on or before March 25, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0007 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Validated Interview and Survey of Outpatient Providers on
Antibiotic Stewardship Interventions (OMB Control No. 0920-1308)--
Reinstatement--Division of Healthcare Quality Promotion (DHQP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Inappropriate antibiotic prescribing is a major driver of
antibiotic resistance which is an urgent national and global health
threat. Additionally, inappropriate antibiotic prescribing contributes
to avoidable adverse drug events that cause substantial harm to
patients. Most antibiotic prescribing originates in traditional
outpatient settings such as physician offices and emergency departments
and at least 30% of these prescriptions are completely unnecessary.
Over the past decade there has been rapid growth in non-traditional
outpatient settings including Urgent Care clinics. Recent evidence
shows that when compared to traditional office settings, inappropriate
antibiotic prescribing is substantially higher in Urgent Care clinics
making this an important priority for antibiotic stewardship. The
design, development, and evaluation of durable stewardship
interventions addressing the unique setting of Urgent Care clinics is
an important area of unmet need. This data will assess knowledge,
attitudes, and practices related to antibiotic prescribing among
clinicians after implementation of a year-long Urgent Care stewardship
initiative.
CDC requests approval for an estimated 62 annual burden hours.
There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Urgent Care Clinician......... Interview Guide. 20 1 1 20
Urgent Care Clinician......... Survey.......... 125 1 20/60 42
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 62
----------------------------------------------------------------------------------------------------------------
[[Page 3549]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-01262 Filed 1-21-22; 8:45 am]
BILLING CODE 4163-18-P
